Recent News

By Category: Countermeasures

U.S. to Buy Japanese-Made Smallpox Vaccine

The United States could spend as much as $34 million for doses of a smallpox vaccine produced in Japan, the Yomiuri Shimbun reported today (see GSN, Dec. 9, 2010). The Chemo-Sero Therapeutic Research Institute said it has a five-year agreement with the U.S. government. The institutes’s vaccine was first created some four decades ago, but Read More »

January 14, 2011
| Filed under Asia/Pacific, North America, Countermeasures, and International
Share

NYC Theaters’ Emergency Preparedness Seen Lacking

Additional steps are needed to prepare Broadway theaters in New York City for a potential WMD attack or other crisis, a New York state legislature subcommittee said yesterday (see GSN, Sept. 23, 2010). The State Assembly’s workplace safety subcommittee in a new report pointed to the unsuccessful Times Square bomb attack last May as evidence Read More »

January 13, 2011
| Filed under North America and Countermeasures
Share

South Korea to Distribute Hundreds of Thousands of Gas Masks

The South Korean government plans to distribute hundreds of thousands of gas masks to protect its citizens from a North Korean chemical weapons strike, Agence France-Presse reported today (see GSN, Oct. 13). The National Emergency Management Agency in 2011 expects to provide residents of five islands near the North-South border with an additional 1,300 gas Read More »

December 13, 2010
| Filed under Asia/Pacific and Countermeasures
Share

WikiLeaks Spotlights Secret Catalog Of Vulnerable Vaccine Facilities

U.S. officials on Monday denounced a WikiLeaks posting that catalogs hundreds of crucial overseas facilities that, if attacked by terrorists, could harm American interests — including vaccine makers, undersea communications cables and mines that supply key metals.

December 9, 2010
| Filed under North America, Countermeasures, and International
Share

DoD Signs Contract To Develop Biological Pathogen Antidotes

The Department of Defense has signed a three year, $8.2 million contract with South Brunswick, New Jersey’s Snowdon, Inc., to develop drug molecules like antidotes and vaccines to protect against eight biological pathogens.